Moira Gunn

This week on #BioTechNation, Dr. Daniel Kraft tells us that we’re moving from Dr. Google to Dr. ChatGPT. Listen Now: biotechnation.com/episodes/a…

This week on #BioTechNation, Lisa Deschamps, CEO of Aviado Bio, tells us how her team is working to correct the gene driving many cases of frontotemporal dementia. Listen Now: biotechnation.com/episodes/c…

Featured on #BioTechNation, Dr. Derek Jantz, Chief Scientific Officer at Tune Therapeutics, joins me to talk about the ability to tune your genome. Tune Therapeutics looks to tune out Hepatitis B! Listen now: biotechnation.com/episodes/t…

Featured on #BioTechNation, Dr. Ned Swanson, Co-Founder, President, and Chief Medical Officer of Polarity Bio, joins me to talk about a new approach to treating wounds. Listen now - biotechnation.com/episodes/a…

Featured on #BioTechNation, Rob Armstrong, CEO of Artax Biopharma Inc., joins me to talk about treating the 40% of all rheumatoid arthritis patients who do not respond to any current drugs. Listen now: biotechnation.com/episodes/t…

Featured on #BioTechNation, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, joins me to talk about how they are testing the use of stem cells to treat babies born with a serious congenital heart defect. Listen now: biotechnation.com/episodes/t…

Featured on #BioTechNation, Dr. Jeff S., President & CEO of Cidara Therapeutics, joins me to talk about promising news regarding a new approach to flu shots. Listen now: biotechnation.com/episodes/a…

Featured on #BioTechNation, Dr. Marc Salzberg, MD, CEO and Chief Medical Officer of Airway Therapeutics, joins me to talk about what they are doing to help preterm babies. Listen now: biotechnation.com/episodes/n…

Featured on #BioTechNation, Dr. Avak Kahvejian, founding CEO of Cellarity, joins me to explain how comparing healthy and diseased cells, along with our understanding of medications, could help treat that disease at its source. Listen now -biotechnation.com/episodes/a…

Featured on #BioTechNation, Paul Hastings, CEO of Nkarta, Inc., joins me to talk about the impact of cuts to NIH research funding and what stepping back from vaccines means for the everyday person and for the biotech industry. Listen now: biotechnation.com/episodes/n…

This week on #BioTechNation, Dr. Neal Kassell shares how focused ultrasound is treating everything from cancer to depression, without surgery, pills, or needles. Listen now: biotechnation.com/episodes/f…

This week on #BioTechNation, Dr. Raza Bokhari shares a new way to treat common skin cancer, no surgery needed. Just a tiny patch that delivers medicine right where it’s needed. Listen now: biotechnation.com/episodes/a…

This week on #BioTechNation, Dr. @EricTopol returns with Part 2 of Super Agers, his bold, evidence-based plan for healthier aging. From AI to gut hormones, he breaks down what’s working, what’s promising, and what needs fixing. Listen now: biotechnation.com/episodes/p…

Recap of Day 3 at #BIO2025: Cross-pollination is the heart that powers healthcare forward. The likes of quantum physics, computer science, and the occasional stroke of luck are some of biology's great assets. #Bio_techNation_2025

Recap of Day 2 at #BIO_techNation_2025: from Austin to zebrafish, our interviewees came (from all over the world) to share some of the world's most exciting biological advancements. Stay tuned to stay inspired! #BIO2025

Name a better duo than BioTech Nation at #BIO2025! Some exciting podcast guests loading... #BIOTechNation2025

In Part Two of our BioTech Nation series, Neurona Therapeutics CEO Dr. Cory Nicholas shares early results from their epilepsy trial: 92% seizure reduction in patients who had no other options. A glimpse into the future of brain repair: biotechnation.com/episodes/p…

This week on BioTech Nation, Dr. Cory Nicholas of Neurona Therapeutics explains how one-time cell therapy may offer lasting seizure relief for people with epilepsy. Part one of a two-part conversation on restoring balance in the brain: biotechnation.com/episodes/p…

This week on #BioTechNation, Dr. Lorin Johnson, CSO at Glycyx Therapeutics is tackling a hidden problem: how opioids prescribed for cancer pain might be blocking immunotherapy from working. A once-daily pill could be the fix. Listen now: biotechnation.com/episodes/f…

This week on #BioTechNation, Brixton Biosciences CEO Sameer Sabir explains how their injectable cold therapy, Neural Ice, could provide lasting relief for osteoarthritis pain without the need for drugs or repeated steroid injections. Listen now: biotechnation.com/episodes/f…